Financings for July 23, 2026
AI Briefing
- Crystalys secures funding for biopharma research.
- Dyne raises capital in private financing.
- Mentari and Neurimmune secure public financings.
Context
Several biopharma and med-tech companies have raised money in public or private financings. Companies included are Crystalys, Dyne, Mentari, Neurimmune, N-Zyme, Royalty, and Tikva.
These financings are significant for the companies involved as they provide necessary funding. The list of companies includes a range of biopharma and med-tech firms that have secured financing.
Advertisement